Endra

Endra (NASDAQ: NDRAU) is commercializing enhanced ultrasound technology for the preclinical research market and leveraging this expertise to develop technologies that improve the capabilities of clinical diagnostic ultrasound, expanding patients' access to safe diagnostic and therapeutic options in situations where expensive X-ray computed tomography (CT) or magnetic resonance imaging (MRI) technologies are unavailable or impractical due to significant medical conditions.